Lung Cancer10.1016/0169-5002(91)90224-t199173203Etoposide versus etoposide plus high-dose cisplatin in the management of advanced non-small cell lung cancer. Results of a prospective randomized FONICAP trial,
Lung Cancer10.1016/s0169-5002(97)89558-x1996161121A randomized phase II study of ifosfamide/mesna/cisplatin plus G-CSF or etoposide/cisplatin plus G-CSF in advanced non-small cell lung cancer: A cancer and leukemia group B study,
Cancer Research and Treatment10.4143/crt.2005.37.6.3322005376332Randomized, Multi-center Phase II Trial of Docetaxel Plus Cisplatin Versus Etoposide Plus Cisplatin as the First-line Therapy for Patients with Advanced Non-Small Cell Lung CancerNam-Su Lee, Hee-Sook Park, Jong-Ho Won, Dae-Sik Hong, Su-Taek Uh, Sang-Jae Lee, Joo-Hang Kim, Se-Kyu Kim, Myung-Ju Ahn, Jung-Hye Choi, Suk-Chul Yang, Jung-Ae Lee, Keun-Seok Lee, Chang-Yeol Yim, Yong-Chul Lee, Chul-Soo Kim, Moon-Hee Lee, Kab-Do Jung, Hanlim Moon, Yl-Sub Lee,
Lung Cancer10.1016/0169-5002(92)90206-y199282139Phase II trial of high-dose cisplatin plus etoposide plus vinblastine in non-small-cell lung cancer. A hoosier oncology group study,
Lung Cancer10.1016/0169-5002(95)90699-11995132224A randomized study of immunotherapy with low-dose subcutaneous interleukin-2 plus melatonin vs chemotherapy with cisplatin and etoposide as first-line therapy for advanced non-small cell lung cancer,
Lung Cancer10.1016/s0169-5002(05)81511-9200549S38940 A phase II randomized trial of vinorelbine plus cisplatin ordocetaxel plus cisplatin in Inoperable, chemo-naïve non-small cell lung cancer patientsY. Chen, J. Shih, C. Tsai, R. Perng, J. Whang-Peng,
Lung Cancer10.1016/0169-5002(91)90436-a199176396A randomised clinical trial of vindesine plus cisplatin versus mitomycin plus vindesine and cisplatin in advanced non-small cell lung cancer,
Seminars in Oncology10.1016/s0093-7754(01)90219-220012810-14Phase III randomized trial of docetaxel in combination with cisplatin or carboplatin or vinorelbine plus cisplatin in advanced non-small cell lung cancer: Interim analysis,
Lung Cancer10.1016/0169-5002(94)90638-61994113-4339-340Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: A randomized trial,
Respirology10.1111/j.1440-1843.1996.tb00010.x19961149-54A phase III randomized trial of cisplatin plus vindesine versus cisplatin plus vindesine plus mitomycin C versus cisplatin plus vindesine plus ifosfamide for advanced non-small-cell lung cancerMasayuki MASUTANI, Hiroshi AKUSAWA, Astushi KADOTA, Yasushi OHCHI, Noriaki TAKAHASHI, Satoshi TANIGAWA, Yoshiaki KOYA, Takashi HORIE,